1-3 of 3
Ellen Neylon, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Results of a Phase 1 Trial of An Oral Histone Deacetylase Inhibitor Belinostat In Patients with Lymphoid Malignancies.

Jasmine M. Zain, MD, Francine M Foss, MD, Johann S. de Bono, Ameet Narwal, Ellen Neylon, RN, BSN, OCN, George Blumenschein, U. Lassen, MD, Poul Knoblauch, Catherine S. Diefenbach, MD, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1787.
https://doi.org/10.1182/blood.V116.21.1787.1787
Published: 2010
Journal Articles

Correlation Between Baseline Methylmalonic Acid Status and Mucositis Severity in the PROPEL Study: Implications for Vitamin Prophylaxis.

Barbara Pro, MD, Bertrand Coiffier, MD, Steven M. Horwitz, MD, Adam Boyd, PhD, Ellen Neylon, RN, Steven Fruchtman, MD, Owen A O'Connor, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1681.
https://doi.org/10.1182/blood.V114.22.1681.1681
Published: 2009
Journal Articles

A Population Pharmacokinetic and Pharmacodynamic Evaluation of Pralatrexate in Patients with Hematologic Malignancies.

Diane R. Mould, PhD, Kevin Sweeney, Stephen Duffull, Ellen Neylon, RN, Owen A. O’Connor, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1370.
https://doi.org/10.1182/blood.V110.11.1370.1370
Published: 2007